1
|
Muto S, Inomata S, Mine H, Watanabe M, Okabe N, Matsumura Y, Shio Y, Suzuki H. P1.15-13 Immune Escape Mechanisms Mediated by B-Catenin in Non-small Cell Lung Cancer. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
2
|
Matsumura Y, Inomata S, Yamaguchi H, Mine H, Takagi H, Watanabe M, Ozaki Y, Muto S, Okabe N, Shio Y, Suzuki H. MA09.05 PD1-Positive Tertiary Lymphoid Structure as a Predictive Factor of Durable Clinical Effect in Immunotherapy for NSCLC. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
3
|
Muto S, Inomata S, Yamaguchi H, Mine H, Takagi H, Ozaki Y, Okabe N, Matsumura Y, Shio Y, Suzuki H. P72.09 Study of Relationship Between Proportion of CTLA-4 Positive Tregs in Tumor Infiltrating Lymphocytes and PD-L1 TPS. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
4
|
Takagi H, Zhao S, Muto S, Mine H, Watanabe M, Ozaki Y, Okabe N, Hasegawa T, Shio Y, Aoki M, Tan C, Shimoyama S, Nakamura K, Inano A, Suzuki H. P1.03-23 Delta-Like 1 Homolog (DLK1) Expression in Non-Small-Cell Lung Cancer and the Development of Radioimmunotherapy Targeting DLK1. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
5
|
Watanabe M, Higashi T, Mine H, Takagi H, Ozaki Y, Muto S, Okabe N, Hasegawa T, Shio Y, Sugimoto K, Chiba H, Suzuki H. P2.06-20 Characterization of Claudin15 as a New Diagnostic Marker for Malignant Pleural Mesotheliomas. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Miyamoto S, Tsuda M, Kato M, Mabe K, Muto S, Ono S, Shimizu Y, Sakamoto N. Evaluation of gastric acid suppression with vonoprazan using calcium carbonate breath test. J Clin Biochem Nutr 2018; 64:174-179. [PMID: 30936631 PMCID: PMC6436034 DOI: 10.3164/jcbn.18-75] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2018] [Accepted: 08/21/2018] [Indexed: 12/18/2022] Open
Abstract
Vonoprazan, a potassium-competitive acid blocker, is a new class of acid-suppressing agent. The acid-inhibitory effect of vonoprazan has been well-documented. However, there is no report on the extent to which the amount of gastric acid secretion is suppressed, not pH measurement, by the use of vonoprazan. The aim of this study was to evaluate this suppression effect. This was a single-arm, interventional pilot study involving 7 healthy Japanese men. The subjects were administered 20 mg vonoprazan for 6 days. The amount of gastric acid secretion was determined using the calcium carbonate breath test. The acid outputs were defined as the maximum Δ13C‰ (Δ13C max) and area under the curve (AUC) during the 30 min sampling period. The Δ13C max and AUC values significantly decreased on the administration of 20 mg vonoprazan. The AUC dropped by approximately 78% on day 1 and by 84% on day 6 and subsequently returned to the control level after cessation of vonoprazan therapy (reduction by 68% on day 7 and by 42% on day 8). In conclusion, the amount of gastric acid secretion rapidly decreased by the administration of vonoprazan; this inhibitory effect was found to be potent and long-lasting. (UMIN ID: UMIN000025469).
Collapse
Affiliation(s)
- Shuichi Miyamoto
- Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-8648, Japan
| | - Momoko Tsuda
- Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-8648, Japan
| | - Mototsugu Kato
- Department of Gastroenterology, National Hospital Organization Hakodate Hospital, 16-gou, 18-banchi, Kawahara-cho, Hakodate, Hokkaido 041-8512, Japan
| | - Katsuhiro Mabe
- Department of Gastroenterology, National Hospital Organization Hakodate Hospital, 16-gou, 18-banchi, Kawahara-cho, Hakodate, Hokkaido 041-8512, Japan
| | - Shuichi Muto
- Department of Gastroenterology, National Hospital Organization Hokkaido Medical Center, 1-banchi, 1-gou, 5-jo, 7-chome, Yamanote, Nishi-ku, Sapporo, Hokkaido 063-0005, Japan
| | - Shoko Ono
- Division of Endoscopy, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-8648, Japan
| | - Yuichi Shimizu
- Division of Endoscopy, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-8648, Japan
| | - Naoya Sakamoto
- Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-8648, Japan
| |
Collapse
|
7
|
Dazai M, Yuki S, Sawada K, Muranaka T, Kawamoto Y, Nakatsumi H, Nakano S, Ishiguro A, Tateyama M, Sato A, Kobayashi Y, Nakamura M, Okuda H, Takahashi Y, Eto K, Muto S, Hatanaka K, Amano T, Sakata Y, Komatsu Y. HGCSG1301: A multicenter, double-blind, randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy431.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
8
|
Nakashima H, Fukushima T, Muto S, Furudono S, Nunohiro T, Maemura K. P1742Effects of sleep-disordered breathing on myocardial stress and renal function in patients with acute myocardial infarction. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- H Nakashima
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - T Fukushima
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - S Muto
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - S Furudono
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - T Nunohiro
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - K Maemura
- Nagasaki University, Graduate School of Biomedical Sciences, Department of Cardiovascular Medicine, Nagasaki, Japan
| |
Collapse
|
9
|
Nakashima H, Fukushima T, Muto S, Furudono S, Nunohiro T, Maemura K. P1248Impact of adherence to continuous positive airway pressure on the long-term clinical outcomes in patients with acute myocardial infarction and obstructive sleep apnea. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- H Nakashima
- Nagasaki Harbor Medical Center, Department of Cardiovascular Medicine, Nagasaki, Japan
| | - T Fukushima
- Nagasaki Harbor Medical Center, Department of Cardiovascular Medicine, Nagasaki, Japan
| | - S Muto
- Nagasaki Harbor Medical Center, Department of Cardiovascular Medicine, Nagasaki, Japan
| | - S Furudono
- Nagasaki Harbor Medical Center, Department of Cardiovascular Medicine, Nagasaki, Japan
| | - T Nunohiro
- Nagasaki Harbor Medical Center, Department of Cardiovascular Medicine, Nagasaki, Japan
| | - K Maemura
- Nagasaki University, Graduate School of Biomedical Sciences, Department of Cardiovascular Medicine, Nagasaki, Japan
| |
Collapse
|
10
|
Ono M, Kato M, Miyamoto S, Tsuda M, Mizushima T, Ono S, Nakagawa M, Mabe K, Nakagawa S, Muto S, Shimizu Y, Kudo M, Katsuki S, Meguro T, Sakamoto N. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan. J Gastroenterol 2018; 53:916-923. [PMID: 29305648 DOI: 10.1007/s00535-017-1428-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2017] [Accepted: 12/27/2017] [Indexed: 02/07/2023]
Abstract
BACKGROUND The Rome III diagnostic criteria had been used to diagnose functional gastrointestinal disorders (FGIDs) world wide, and functional bowel disorders (FBDs) including irritable bowel syndrome (IBS) have recently attracted the attention of Japanese physicians. However, there have been few reports on the prevalence of FBDs diagnosed by the Rome III diagnostic criteria. AIMS The aim of this study was to determine the prevalence of FBDs diagnosed according to the diagnostic criteria of Rome III in Japan. PATIENTS AND METHODS All patients who were booked for colonoscopy were enrolled from eight institutions in Japan. This study was a prospective observational study in the period from April 2013 to December 2013. Patients filled out FGID questionnaires of Rome III when they were waiting for colonoscopy. RESULTS Data for 1200 patients who underwent colonoscopy were analyzed. A total of 547 patients (45.6%) were diagnosed with FBDs. Out of those patients, 9.1% had IBS. According to the Rome III diagnostic criteria, 134 patients (11.2%) had functional bloating (FB), 73 (6.1%) had functional constipation (FC), 40 (3.3%) had functional diarrhea (FD), and 191 (15.9%) had unspecified functional bowel disorder (UFBD). Patients with FBDs had significantly higher rates of almost all symptoms (abdominal pain, hard or lumpy stools, loose or watery stools, and bloating) than those in the controls. CONCLUSIONS In Japan, the prevalence of FBDs and IBS is high, similar to that in the US. Many patients with FBDs have multiple symptoms.
Collapse
Affiliation(s)
- Masayoshi Ono
- Department of Gastroenterology, Hakodate Municipal Hospital, 1-10-1 Minato-cho, Hakodate, Hokkaido, 041-8680, Japan.
| | - Mototsugu Kato
- Department of Gastroenterology, National Hospital Organization Hakodate Hospital, Hakodate, Japan
| | - Shuichi Miyamoto
- Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
| | - Momoko Tsuda
- Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
| | - Takeshi Mizushima
- Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
| | - Shouko Ono
- Division of Endoscopy, Hokkaido University Hospital, Sapporo, Japan
| | - Manabu Nakagawa
- Division of Endoscopy, Hokkaido University Hospital, Sapporo, Japan
| | - Katsuhiro Mabe
- Department of Gastroenterology, National Hospital Organization Hakodate Hospital, Hakodate, Japan
| | - Soichi Nakagawa
- Division of Endoscopy, Hokkaido University Hospital, Sapporo, Japan
| | - Shuichi Muto
- Department of Gastroenterology, National Hospital Organization, Hokkaido Medical Center, Sapporo, Japan
| | - Yuichi Shimizu
- Division of Endoscopy, Hokkaido University Hospital, Sapporo, Japan
| | - Mineo Kudo
- Department of Gastroenterology, Touei Hospital, Sapporo, Japan
| | - Shinichi Katsuki
- Center of Gastroenterology, Otaru Ekisaikai Hospital, Otaru, Japan
| | - Takashi Meguro
- Department of Gastroenterology, Hokkaido Gastroenterology Hospital, Sapporo, Japan
| | - Naoya Sakamoto
- Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
| |
Collapse
|
11
|
Nakashima H, Fukushima T, Muto S, Furudono S, Nunohiro T, Maemura K. P1251Impact of obstructive sleep apnea on circadian variation of infarct size in patients with acute myocardial infarction. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- H Nakashima
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - T Fukushima
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - S Muto
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - S Furudono
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - T Nunohiro
- Nagasaki Harbor Medical Center, Cardiovascular Medicine, Nagasaki, Japan
| | - K Maemura
- Nagasaki University, Graduate School of Biomedical Sciences, Department of Cardiovascular Medicine, Nagasaki, Japan
| |
Collapse
|
12
|
Nakamura M, Komatsu Y, Muranaka T, Yagisawa M, Kawamoto Y, Nakatsumi H, Yuki S, Saiki T, Ishiguro A, Tateyama M, Kobayashi Y, Miyagishima T, Takahata T, Sato A, Dazai M, Okuda H, Fujikawa K, Eto K, Muto S, Hatanaka K, Amano T, Sakata Y. HGCSG 1301: A Multicenter, Double-Blind, Randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
13
|
Tsunematsu S, Muto S, Oi H, Naka T, Kitagataya T, Sasaki R, Taya Y, Baba U, Tsukamoto Y, Uemura K, Kimura T, Ohara Y. Surgically Diagnosed Primary Hepatic Angiosarcoma. Intern Med 2018; 57:687-691. [PMID: 29151516 PMCID: PMC5874340 DOI: 10.2169/internalmedicine.9318-17] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Primary hepatic angiosarcoma is a rare tumor originating from endothelial cells in the liver and accounts for approximately 1% of all hepatic malignant tumors. It is difficult to diagnose due to the lack of specific symptoms or tumor markers. No effective treatment exists, but complete surgical resection may achieve a good outcome. Since most primary hepatic angiosarcomas are already at an advanced stage at diagnosis, few reports describe tumors smaller than 2 cm. We report a case of surgery for a 1.7-cm sized primary hepatic angiosarcoma. Further studies are required to improve the preoperative diagnosis of primary hepatic angiosarcoma.
Collapse
Affiliation(s)
- Seiji Tsunematsu
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | - Shuichi Muto
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | - Hiroki Oi
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | - Tomoaki Naka
- Department of Surgical Pathology, Hokkaido University Hospital, Japan
| | - Takashi Kitagataya
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | - Rui Sasaki
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | - Yoko Taya
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | - Urara Baba
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | - Yuki Tsukamoto
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | | | - Toshio Kimura
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| | - Yukio Ohara
- Department of Gastroenterology and Hepatology, Hokkaido Medical Center, Japan
| |
Collapse
|
14
|
Furudono S, Mashimo Y, Fukushima T, Kurobe M, Muto S, Suenaga H, Nunohiro T, Takeshita S, Nakashima H, Maemura K. P1123Impact of central and obstructive sleep apnea on long term clinical outcomes in patients with acute myocardial infarction. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p1123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Furudono S, Mashimo Y, Fukushima T, Kurobe M, Muto S, Suenaga H, Nunohiro T, Takeshita S, Nakashima H, Maemura K. P4633Relationship between circadian variation and plaque characteristics in patients with ST-segment elevation myocardial Infarction. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
16
|
Komori A, Morisaki T, Mutoh T, Sakakibara S, Takeiri Y, Kumazawa R, Kubo S, Ida K, Morita S, Narihara K, Shimozuma T, Tanaka K, Watanabe KY, Yamada H, Yoshinuma M, Akiyama T, Ashikawa N, Emoto M, Funaba H, Goto M, Ido T, Ikeda K, Inagaki S, Isobe M, Igami H, Itoh K, Kaneko O, Kawahata K, Kobuchi T, Masuzaki S, Matsuoka K, Minami T, Miyazawa J, Muto S, Nagayama Y, Nakamura Y, Nakanishi H, Narushima Y, Nishimura K, Nishiura M, Nishizawa A, Noda N, Ohdachi S, Oka Y, Osakabe M, Ohyabu N, Ozaki T, Peterson BJ, Sagara A, Saito K, Sakamoto R, Sato K, Sato M, Seki T, Shoji M, Sudo S, Tamura N, Toi K, Tokuzawa T, Tsumori K, Uda T, Watari T, Yamada I, Yokoyama M, Yoshimura Y, Motojima O, Beidler CD, Fujita T, Isayama A, Sakamoto Y, Takenaga H, Goncharov P, Ishii K, Sakamoto M, Murakami S, Notake T, Takeuchi N, Okajima S, Sasao M. Overview of Progress in LHD Experiments. Fusion Science and Technology 2017. [DOI: 10.13182/fst06-a1229] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- A. Komori
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Morisaki
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Mutoh
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - S. Sakakibara
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - Y. Takeiri
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - R. Kumazawa
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - S. Kubo
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Ida
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - S. Morita
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Narihara
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Shimozuma
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Tanaka
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Y. Watanabe
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - H. Yamada
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Yoshinuma
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Akiyama
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - N. Ashikawa
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Emoto
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - H. Funaba
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Goto
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Ido
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Ikeda
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - S. Inagaki
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Isobe
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - H. Igami
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Itoh
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - O. Kaneko
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Kawahata
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Kobuchi
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - S. Masuzaki
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Matsuoka
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Minami
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - J. Miyazawa
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - S. Muto
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - Y. Nagayama
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - Y. Nakamura
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - H. Nakanishi
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - Y. Narushima
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Nishimura
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Nishiura
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - A. Nishizawa
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - N. Noda
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - S. Ohdachi
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - Y. Oka
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Osakabe
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - N. Ohyabu
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Ozaki
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - B. J. Peterson
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - A. Sagara
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Saito
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - R. Sakamoto
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Sato
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Sato
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Seki
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Shoji
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - S. Sudo
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - N. Tamura
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Toi
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Tokuzawa
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - K. Tsumori
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Uda
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - T. Watari
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - I. Yamada
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - M. Yokoyama
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - Y. Yoshimura
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - O. Motojima
- National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
| | - C. D. Beidler
- Max-Planck Institut fuer Plasmaphysik, Greifswald D-17491, Germany
| | - T. Fujita
- Japan Atomic Energy Research Institute, Naka 311-0193, Japan
| | - A. Isayama
- Japan Atomic Energy Research Institute, Naka 311-0193, Japan
| | - Y. Sakamoto
- Japan Atomic Energy Research Institute, Naka 311-0193, Japan
| | - H. Takenaga
- Japan Atomic Energy Research Institute, Naka 311-0193, Japan
| | - P. Goncharov
- Graduate University for Advanced Studies, School of Mathematical and Physical Science Department of Fusion Science, Hayama 240-0193, Japan
| | - K. Ishii
- Kyushu University, Research Institute for Applied Mechanics Kasuga 816-8580, Japan
| | - M. Sakamoto
- Kyushu University, Research Institute for Applied Mechanics Kasuga 816-8580, Japan
| | - S. Murakami
- Kyoto University, Department of Nuclear Engineering, Kyoto 606-8501, Japan
| | - T. Notake
- Nagoya University, Department of Energy Engineering and Science Nagoya 464-8603, Japan
| | - N. Takeuchi
- Nagoya University, Department of Energy Engineering and Science Nagoya 464-8603, Japan
| | - S. Okajima
- Chubu University, Kasugai, Aichi 487-8501, Japan
| | - M. Sasao
- Tohoku University, Graduate School of Engineering, Sendai 980-8579, Japan
| | | |
Collapse
|
17
|
Morita S, Goto M, Muto S, Zhou HY, Dong CF. Core Impurity Transport Studies from Different Diagnostic Approaches in LHD. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10796] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- S. Morita
- National Institute for Fusion Science, Toki 509-5292, Gifu, Japan
| | - M. Goto
- National Institute for Fusion Science, Toki 509-5292, Gifu, Japan
| | - S. Muto
- National Institute for Fusion Science, Toki 509-5292, Gifu, Japan
| | - H. Y. Zhou
- The Graduate University for Advanced Studies, Toki 509-5292, Gifu, Japan
| | - C. F. Dong
- The Graduate University for Advanced Studies, Toki 509-5292, Gifu, Japan
| | | |
Collapse
|
18
|
Shimozuma T, Yokoyama M, Ida K, Takeiri Y, Kubo S, Murakami S, Wakasa A, Idei H, Yoshimura Y, Notake T, Inagaki S, Tamura N, Toi K, Ohyabu N, Osakabe M, Ikeda K, Tsumori K, Oka Y, Nagaoka K, Kaneko O, Yamada I, Narihara K, Nagayam Y, Muto S, Tanaka K, Tokuzawa T, Morita S, Goto M, Yoshinuma M, Funaba H, Morisaki T, Watanabe KY, Miyazawa J, Mutoh T, Watari T, Ohkubo K. Improvement of Plasma Core Confinement Via Electron-Root Realization by Strongly Focused ECRH in LHD: Core Electron-Root Confinement. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10791] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- T. Shimozuma
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Yokoyama
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Ida
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Takeiri
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Kubo
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Murakami
- Kyoto University, Department of Nuclear Engineering, Kyoto 606-8501, Japan
| | - A. Wakasa
- Kyoto University, Department of Nuclear Engineering, Kyoto 606-8501, Japan
| | - H. Idei
- Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - Y. Yoshimura
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Notake
- RIKEN, Tera-Photonics Laboratory, Aoba Sendai-City, Miyagi 980-0845, Japan
| | - S. Inagaki
- Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - N. Tamura
- Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - K. Toi
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - N. Ohyabu
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Osakabe
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Ikeda
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Tsumori
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Oka
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Nagaoka
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - O. Kaneko
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - I. Yamada
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Narihara
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Nagayam
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Muto
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Tanaka
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Tokuzawa
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Morita
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Goto
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Yoshinuma
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - H. Funaba
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Morisaki
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Y. Watanabe
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - J. Miyazawa
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Mutoh
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Watari
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Ohkubo
- National Institute for Fusion Science, Toki 509-5292, Japan
| | | |
Collapse
|
19
|
Affiliation(s)
- S. Ohdachi
- National Institute for Fusion Science, Toki-shi 509-5292, Japan
| | - F. Watanabe
- National Institute for Fusion Science, Toki-shi 509-5292, Japan
| | - S. Yamamoto
- National Institute for Fusion Science, Toki-shi 509-5292, Japan
| | - K. Toi
- National Institute for Fusion Science, Toki-shi 509-5292, Japan
| | - C. Suzuki
- National Institute for Fusion Science, Toki-shi 509-5292, Japan
| | - K. Ida
- National Institute for Fusion Science, Toki-shi 509-5292, Japan
| | - S. Muto
- National Institute for Fusion Science, Toki-shi 509-5292, Japan
| | | |
Collapse
|
20
|
Muto S, Hayashi M, Matsushita N, Momose Y, Shibata N, Umemura T, Matsumoto K. Systemic and Eosinophilic Lesions in Rats with Spontaneous Eosinophilia (mes Rats). Vet Pathol 2016; 38:346-50. [PMID: 11355670 DOI: 10.1354/vp.38-3-346] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The mes rat is from an inbred mutant colony of rats with spontaneous eosinophilia. In order to investigate the pathogenesis of the mes rat, the histopathology and hematology for 76 mes rats were examined at several weeks of age. Tissue eosinophilia developed at 8 weeks of age when the blood eosinophil was 500 cells per microliter or more. Subsequently, eosinophilia progressed with age, and splenic eosinophilopoiesis and erythropoiesis appeared simultaneously. Many inflammatory lesions were induced after 10 weeks of age when the blood eosinophils became 1,000 cells per microliter or more. Gastroenteritis and mesenteric lymphadenitis were seen in 44 of 47 (94%) and 31 of 47 (66%) rats, respectively, after 10 weeks of age. Aortitis that deteriorated with age was found in 19 of 39 (49%) rats after 12 weeks of age. Hepatic fibrosis was found in four rats that exhibited severe eosinophilia and anemia. These results are comparable to the features of a hypereosinophilic syndrome in humans and other animals.
Collapse
Affiliation(s)
- S Muto
- Toxicology Laboratories, R&D, Kissei Pharmaceutical Co., Ltd.,
| | | | | | | | | | | | | |
Collapse
|
21
|
Muto S, Kawakubo M, Matsushita N, Maeda N, Momose Y, Matsumoto K. Haematological data for Matsumoto Eosinophilic Shinshu rats as determined by an automated haematology analyser. Lab Anim 2016; 39:122-9. [PMID: 15703134 DOI: 10.1258/0023677052886556] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The Matsumoto Eosinophilic Shinshu (MES) rat originated from an inbred mutant colony of rats with spontaneous eosinophilia. As part of an investigation of the pathogenesis of the MES rat, we examined the haematology data for 106 males and 88 females and age-associated changes using an automated haematology analyser, flow cytometric analysis and morphological examination. The data at 10 weeks of age showed the MES rats had higher counts for eosinophils and neutrophils, slightly higher counts for lymphocytes, monocytes, basophils, and large unstained cells (LUCs), and slightly lower values for the erythrocytic parameters when compared with Sprague-Dawley (SD) rats. In data for MES rats aged 8 to 20 weeks, eosinophil counts increased with age up to 20 weeks together with some increased neutrophil counts. After 11 weeks of age, counts for lymphocytes, monocytes, basophils, and LUCs in the MES rats were also slightly increased. In female MES rats, flow cytometric analysis showed increased counts for pan-T+ cells, but blasts, abnormal granulocytes and lymphocytes were not detected morphologically. The MES rat characterized by the haematological findings could be a useful animal model for studies of hypereosinophilia.
Collapse
Affiliation(s)
- S Muto
- Toxicology Research Laboratory, R&D, Kissei Pharmaceutical Co., Ltd, 2320-1 Maki, Hotaka, Minamiazumi, Nagano 399-8305, Japan.
| | | | | | | | | | | |
Collapse
|
22
|
Yoshizawa H, Morishita Y, Watanabe M, Ishibashi K, Muto S, Kusano E, Nagata D. TGF-β₁-siRNA delivery with nanoparticles inhibits peritoneal fibrosis. Gene Ther 2015; 22:333-40. [PMID: 25567535 DOI: 10.1038/gt.2014.116] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2014] [Revised: 11/06/2014] [Accepted: 11/11/2014] [Indexed: 12/19/2022]
Abstract
Gene therapies may be promising for the treatment of peritoneal fibrosis (PF) in subjects undergoing peritoneal dialysis (PD). However, a method of delivery of treatment genes to the peritoneum is lacking. We attempted to develop an in vivo small interfering RNA (siRNA) delivery system with liposome-based nanoparticles (NPs) to the peritoneum to inhibit PF. Transforming growth factor (TGF)-β1-siRNAs encapsulated in NPs (TGF-β1-siRNAs-NPs) dissolved in PD fluid were injected into the peritoneum of mice with PF three times a week for 2 weeks. TGF-β1-siRNAs-NPs knocked down TGF-β1 expression significantly in the peritoneum and inhibited peritoneal thickening with fibrous changes. TGF-β1-siRNAs-NPs also inhibited the increase of expression of α-smooth muscle actin-positive myofibroblasts. These results suggest that the TGF-β1-siRNA delivery system with NPs described here could be an effective therapeutic option for PF in subjects undergoing PD.
Collapse
Affiliation(s)
- H Yoshizawa
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan
| | - Y Morishita
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan
| | - M Watanabe
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan
| | - K Ishibashi
- Department of Medical Physiology, Meiji Pharmaceutical University, Tokyo, Japan
| | - S Muto
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan
| | - E Kusano
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan
| | - D Nagata
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan
| |
Collapse
|
23
|
Takeda H, Nakagawa K, Okubo N, Nishimura M, Muto S, Ohnishi S, Sakamoto N, Hosono H, Asaka M. Pathophysiologic basis of anorexia: focus on the interaction between ghrelin dynamics and the serotonergic system. Biol Pharm Bull 2014; 36:1401-5. [PMID: 23995649 DOI: 10.1248/bpb.b13-00364] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Anorexia is an important issue in the management of elderly patients with cancer because it contributes to the development of malnutrition, increases morbidity and mortality, and negatively affects patients' quality of life. This review summarizes the potential mechanisms of the development of anorexia in three animal models that mimic the situations commonly seen in elderly patients receiving chemotherapy. Cisplatin-induced anorexia is attributable to a decrease in peripheral and central ghrelin secretion caused by the stimulation of serotonin (5-hydroxytryptamine; 5-HT)2B and 5-HT2C receptors via 5-HT secretion. Age-associated anorexia is caused by an increase in plasma leptin, which results from disturbed reactivity of ghrelin in the hypothalamus and regulation of ghrelin secretion. Environmental change causes the activation of central 5-HT1B and 5-HT2C receptors and the melanocortin-4 receptor system, resulting in a decrease in circulating ghrelin levels which lowers food intake. New therapeutic approaches based on these pathophysiological mechanisms are warranted for the treatment of anorexia in cancer patients, especially elderly ones.
Collapse
Affiliation(s)
- Hiroshi Takeda
- Pathophysiology and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Akiyama S, Uehara A, Sugawara S, Ogasawara K, Shibata H, Kawahara M, Miura M, Muto S, Mori T, Ishioka C. A Workshop Promoting and Spreading Team Medical Care and Regional Collaboration for Cancer Patients. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt460.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
25
|
Akimoto T, Kimura T, Watanabe Y, Ishikawa N, Iwazu Y, Saito O, Muto S, Yagisawa T, Kusano E. The impact of nephrectomy and renal transplantation on serum levels of soluble Klotho protein. Transplant Proc 2013; 45:134-6. [PMID: 23375286 DOI: 10.1016/j.transproceed.2012.07.150] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2012] [Revised: 06/29/2012] [Accepted: 07/11/2012] [Indexed: 12/29/2022]
Abstract
BACKGROUND Klotho, a single-pass transmembrane protein primarily expressed in the kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can be cleaved and released as a soluble form. However, information regarding the origins and kinetics of soluble serum Klotho remains poorly understood. We evaluated serial changes in serum Klotho levels among living donors before and after retroperitoneoscopic nephrectomy as well as in their renal transplant recipients. METHODS The levels of soluble Klotho in serum obtained from 10 living donors and their renal transplant recipients were determined using a sandwich enzyme-linked immunosorbent assay system. RESULTS Serum soluble Klotho was detectable in all subjects. The baseline serum Klotho concentrations in the living donors ranged from 726.4 to 1417.1 pg/mL (median, 909.8 pg/mL; interquartile ranges [IR], 754.8-1132.4), whereas that in the concomitant renal transplant recipients ranged from 397.5 to 1047.2 pg/mL (median, 613.0 pg/mL; IR, 445.9-750.8; P = .003). The levels of soluble serum Klotho measured 5 days after retroperitoneoscopic nephrectomy (median, 619.0 pg/mL; IR, 544.6-688.5; P = .001) were significantly lower than the baseline values. Among the renal transplant recipients, no significant changes in serum Klotho levels were observed during the observation period. CONCLUSION Our data regarding soluble serum Klotho levels obtained from living donors support the idea that the kidneys are a major source of soluble serum Klotho in human subjects without a deterioration of renal function. In recipients, concomitant acute kidney injuries and immunosuppressive protocols might modulate the release of soluble Klotho from the grafts into the circulation.
Collapse
Affiliation(s)
- T Akimoto
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Muto S, Tatsumi K, Rusz J. Parameter-free extraction of EMCD from an energy-filtered diffraction datacube using multivariate curve resolution. Ultramicroscopy 2013; 125:89-96. [DOI: 10.1016/j.ultramic.2012.09.008] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2012] [Revised: 09/15/2012] [Accepted: 09/23/2012] [Indexed: 11/30/2022]
|
27
|
Sogabe S, Fukushima H, Yuki S, Kobayashi Y, Miyagishima T, Okuda H, Kusumi T, Doi A, Tsuji Y, Kawamoto Y, Ehira N, Koike M, Meguro T, Takahashi Y, Yoshizaki K, Muto S, Ishiguro A, Kato S, Sakata Y, Komatsu Y. Retrospective cohort study on the safety and efficacy of panitumumab (Pmab) for patients with metastatic colorectal cancer (mCRC): The HGCSG1002 study—Analysis of clinical early predictor for the efficacy. J Clin Oncol 2013. [DOI: 10.1200/jco.2013.31.4_suppl.593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
593 Background: Inhibition of the EGFR pathway has become a key part in the treatment of colorectal cancer. There were few studies for clinical early predictive markers. To investigate the early magnesium (Mg2+), calcium (Ca2+), albumin (Alb), CEA and CA 19-9 plasma level reductions as a predictor for clinical outcome in terms of progression free survival (PFS) and overall survival (OS). Methods: 200 patients (pts) with mCRC treated by Pmab contained chemotherapy were retrospectively registered from 20 centers in Japan (HGCSG 1002 study). Of these, the pts that were refractory to or intolerant for 5-FU/ irinotecan/ oxaliplatin, and were never administered anti-EGFR-antibody, were included in this analysis. Mg2+, Ca2+, Alb, CEA and CA19-9 plasma levels were obtained from medical records. The differences in terms of PFS and OS according to the presence of Mg2+, Ca2+, Alb, CEA and CA19-9 reductions were evaluated by the log-rank test. Results: Of 67 pts were able to evaluate for this analysis. Pts’ characteristics were as follows: male/female 38/29, median age 64 (range 45-81), ECOG PS (0/1/2- ) 45/17/5. Response rate and disease control rate were 16.4% and 65.7%, PFS and OS were 4.3 m and 12.4 m, respectively. There were no correlations between Ca/Alb plasma level reductions and PFS/OS. Mg2+ reduction of at least 50% respect to the basal value during the course of treatment was significantly correlated with improved OS and PFS (OS, P=0.03; PFS, P=0.01), but the early reduction (until the 4th week or the 8th week after start of chemotherapy) was not correlated with OS and PFS. An early CEA serum level reduction of at least 40% until the 8th week was significantly correlated with improved OS and PFS (OS, P=0.04; PFS, P=0.07), moreover of at least 30% until the 4th week was correlated to longer PFS (P=0.053). Similar results were seen in CA19-9. Conclusions: An early CEA plasma level reduction of at least 30% or 40% was suggested to be a predictor for PFS in Pmab containing chemotherapy for mCRC pts. Although Mg2+ serum level reduction was correlated to clinical outcome, but could not show that is an early predictor for PFS and OS in our study.
Collapse
Affiliation(s)
- Susumu Sogabe
- Internal Medicine, Kushiro Rosai Hospital, Kushiro, Japan
| | - Hiraku Fukushima
- Department of Cancer Center, Hokkaido University Hospital, Sapporo, Japan
| | - Satoshi Yuki
- Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
| | - Yoshimitsu Kobayashi
- Department of Gastroenterology, Hokkaido University School of Medicine, Sapporo, Japan
| | | | - Hiroyuki Okuda
- Department of Medical Oncology, Keiyukai Sapporo Hospital, Sapporo, Japan
| | | | - Ayako Doi
- KKR Sapporo Medical Center Tonan Hospital, Sapporo, Japan
| | - Yasushi Tsuji
- KKR Sapporo Medical Center Tonan Hospital, Hokkaido, Japan
| | - Yasuyuki Kawamoto
- Department of Gastroenterology, Hakodate City Hospital, Hakodate, Japan
| | | | | | | | - Yasuo Takahashi
- Department of Gastroenterology, Hokkaido Cancer Center, Sapporo, Japan
| | | | | | | | - Sosuke Kato
- Sapporo Social Insurance General Hospital, Sapporo, Japan
| | - Yuh Sakata
- Department of Medical Oncology, Misawa City Hospital, Misawa, Japan
| | - Yoshito Komatsu
- Department of Cancer Center, Hokkaido University Hospital, Sapporo, Japan
| | | |
Collapse
|
28
|
Nakatsumi H, Komatsu Y, Yuki S, Sogabe S, Tateyama M, Muto S, Kudo M, Kato K, Miyagishima T, Uebayashi M, Meguro T, Oba K, Asaka M. Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot study. Chemotherapy 2013; 58:439-44. [PMID: 23364217 DOI: 10.1159/000345920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2012] [Accepted: 11/18/2012] [Indexed: 11/19/2022]
Abstract
BACKGROUND Indisetron is a serotonin (5-hydroxytryptamine type 3) receptor antagonist that also antagonizes 5-hydroxytryptamine type 4 receptors. We designed a pilot study in order to explore the optimal dosing period for indisetron during modified FOLFOX6 (mFOLFOX6). PATIENTS AND METHODS Forty-two chemotherapy-naive patients with advanced colorectal cancer scheduled to receive mFOLFOX6 were randomly assigned to either a 1- or 3-day indisetron regimen arm. The primary endpoint was complete protection from vomiting. RESULTS Proportions of patients with complete protection from vomiting were 85.7% [95% confidence interval (CI) 63.7-97.0] with the 3-day regimen and 81.0% (95% CI 58.1-94.6) with the 1-day regimen. Proportions of patients with complete protection from nausea were 47.6% in each arm (95% CI 25.7-70.2). No rescue therapy rates were 66.7% (95% CI 43.0-85.4) versus 57.1% (95% CI 34.0-78.2). No severe adverse events were observed in either arm. CONCLUSION Both 1- and 3-day indisetron regimens were feasible for preventing nausea and vomiting induced by mFOLFOX6.
Collapse
Affiliation(s)
- Hiroshi Nakatsumi
- Department of Internal Medicine, Wakkanai City Hospital, Wakkanai, Hokkaido 097-8555, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Takeda H, Muto S, Nakagawa K, Ohnishi S, Asaka M. Rikkunshito and Ghrelin Secretion. Curr Pharm Des 2012; 18:4827-38. [DOI: 10.2174/138161212803216933] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2012] [Accepted: 04/05/2012] [Indexed: 11/22/2022]
|
30
|
Harada T, Ohkubo I, Lippmaa M, Sakurai Y, Matsumoto Y, Muto S, Koinuma H, Oshima M. Spin-filter tunnel junction with matched fermi surfaces. Phys Rev Lett 2012; 109:076602. [PMID: 23006390 DOI: 10.1103/physrevlett.109.076602] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2012] [Indexed: 06/01/2023]
Abstract
Efficient injection of spin-polarized current into a semiconductor is a basic prerequisite for building semiconductor-based spintronic devices. Here, we use inelastic electron tunneling spectroscopy to show that the efficiency of spin-filter-type spin injectors is limited by spin scattering of the tunneling electrons. By matching the Fermi-surface shapes of the current injection source and target electrode material, spin injection efficiency can be significantly increased in epitaxial ferromagnetic insulator tunnel junctions. Our results demonstrate that not only structural but also Fermi-surface matching is important to suppress scattering processes in spintronic devices.
Collapse
Affiliation(s)
- T Harada
- Department of Applied Chemistry, The University of Tokyo, Hongo, Bunkyo-ku, Japan
| | | | | | | | | | | | | | | |
Collapse
|
31
|
Ohtsubo T, Stone NJ, Stone JR, Towner IS, Bingham CR, Gaulard C, Köster U, Muto S, Nikolov J, Nishimura K, Simpson GS, Soti G, Veskovic M, Walters WB, Wauters F. Magnetic dipole moment of the doubly-closed-shell plus one proton nucleus 49Sc. Phys Rev Lett 2012; 109:032504. [PMID: 22861842 DOI: 10.1103/physrevlett.109.032504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2012] [Indexed: 06/01/2023]
Abstract
The nucleus 49Sc, having a single f(7/2) proton outside doubly magic 48Ca (Z=20, N=28), is one of the very few isotopes which makes possible testing of the fundamental theory of nuclear magnetism. The magnetic moment has been measured by online β NMR of nuclei oriented at milli-Kelvin temperatures to be (+)5.616(25) μ(N). The result is discussed in terms of a detailed theory of the structure of the magnetic moment operator, showing excellent agreement with calculated departure from the f(7/2) Schmidt limit extreme single-particle value. The measurement completes the sequence of moments of Sc isotopes with even numbers of f(7/2) neutrons: the first such isotopic chain between two major shells for which a full set of moment measurements exists. The result further completes the isotonic sequence of ground-state moments of nuclei with an odd number of f(7/2) protons coupled to a closed subshell of f(7/2) neutrons. Comparison with a recent shell-model calculation of the latter sequence is made.
Collapse
Affiliation(s)
- T Ohtsubo
- Department of Physics, Niigata University, Niigata 950-2181, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Nahata M, Muto S, Oridate N, Ohnishi S, Nakagawa K, Sadakane C, Saegusa Y, Hattori T, Asaka M, Takeda H. Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease. Am J Physiol Gastrointest Liver Physiol 2012; 303:G42-53. [PMID: 22517773 PMCID: PMC3404573 DOI: 10.1152/ajpgi.00462.2011] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Gastroesophageal reflux disease (GERD) is often associated with decreased upper gastrointestinal motility, and ghrelin is an appetite-stimulating hormone known to increase gastrointestinal motility. We investigated whether ghrelin signaling is impaired in rats with GERD and studied its involvement in upper gastrointestinal motility. GERD was induced surgically in Wistar rats. Rats were injected intravenously with ghrelin (3 nmol/rat), after which gastric emptying, food intake, gastroduodenal motility, and growth hormone (GH) release were investigated. Furthermore, plasma ghrelin levels and the expression of ghrelin-related genes in the stomach and hypothalamus were examined. In addition, we administered ghrelin to GERD rats treated with rikkunshito, a Kampo medicine, and examined its effects on gastroduodenal motility. GERD rats showed a considerable decrease in gastric emptying, food intake, and antral motility. Ghrelin administration significantly increased gastric emptying, food intake, and antral and duodenal motility in sham-operated rats, but not in GERD rats. The effect of ghrelin on GH release was also attenuated in GERD rats, which had significantly increased plasma ghrelin levels and expression of orexigenic neuropeptide Y/agouti-related peptide mRNA in the hypothalamus. The number of ghrelin-positive cells in the gastric body decreased in GERD rats, but the expression of gastric preproghrelin and GH secretagogue receptor mRNA was not affected. However, when ghrelin was exogenously administered to GERD rats treated with rikkunshito, a significant increase in antral motility was observed. These results suggest that gastrointestinal dysmotility is associated with impaired ghrelin signaling in GERD rats and that rikkunshito restores gastrointestinal motility by improving the ghrelin response.
Collapse
Affiliation(s)
- Miwa Nahata
- Dept. of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Hokkaido, Japan.
| | - Shuichi Muto
- Departments of 2Gastroenterology and Hematology and ,3Department of Gastroenterology, Tomakomai City General Hospital, Shimizu, Tomakomai, Hokkaido, Japan
| | - Nobuhiko Oridate
- 4Otolaryngology-Head and Neck Surgery, Hokkaido University Graduate School of Medicine, and
| | | | - Koji Nakagawa
- 5Department of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Hokkaido;
| | - Chiharu Sadakane
- 1Tsumura Research Laboratories, Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki; ,5Department of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Hokkaido;
| | - Yayoi Saegusa
- 1Tsumura Research Laboratories, Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki; ,5Department of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Hokkaido;
| | - Tomohisa Hattori
- 1Tsumura Research Laboratories, Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki;
| | | | - Hiroshi Takeda
- Departments of 2Gastroenterology and Hematology and ,5Department of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Hokkaido;
| |
Collapse
|
33
|
Isotani S, Muto S, Yu J, Nagae M, China T, Koseki T, Kumamoto T, Tokiwa S, Yoshii T, Saito K, Yamaguchi R, Ide H, Horie S. Clinical and safety profiles of bipolar transurethral vaporization of the prostate in saline: a preliminary report. Asian J Endosc Surg 2012; 5:21-4. [PMID: 22776338 DOI: 10.1111/j.1758-5910.2011.00114.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Transurethral vaporization of the prostate in saline (TURisV) is an innovative endoscopic surgical modality for the treatment of benign prostatic hyperplasia (BPH) that vaporizes prostate tissue using a uniquely designed mushroom electrode. TURisV promises instant hemostatic tissue ablation under saline irrigation and offers clinical advantages for endoscopic BPH operations. From July 2008 to February 2009, TURisV was performed in 17 cases with clinically significant BPH. Median operation time was 127.0 min and median volume of vaporized prostate tissue was 41.1 g. Median International Prostate Symptom Score improved from 20 to 4 after 12 months. Median maximum flow rate increased from 5.3 mL/s to 13.8 mL/s after 12 months. Postoperative median residual urine improved from 48.0 mL to 7.0 mL after 12 months. No changes in hemoglobin or electrolyte levels were seen postoperatively. Our results suggest that TURisV is a safe and efficacious treatment for BPH.
Collapse
Affiliation(s)
- S Isotani
- Department of Urology, Teikyo University, Tokyo, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Takeda H, Muto S, Nakagawa K, Ohnishi S, Sadakane C, Saegusa Y, Nahata M, Hattori T, Asaka M. Rikkunshito as a Ghrelin Enhancer. Methods Enzymol 2012; 514:333-51. [DOI: 10.1016/b978-0-12-381272-8.00021-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
35
|
Takeda SI, Chinda J, Murakami T, Numata A, Iwazu Y, Akimoto T, Hamano Y, Muto S, Takahashi M, Kusano E. Development of features of glomerulopathy in tumor-bearing rats: a potential model for paraneoplastic glomerulopathy. Nephrol Dial Transplant 2011; 27:1786-92. [DOI: 10.1093/ndt/gfr565] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Ogawa H, Azuma M, Muto S, Nishioka Y, Honjo A, Tezuka T, Uehara H, Izumi K, Itai A, Sone S. IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma. Clin Exp Allergy 2011; 41:104-15. [PMID: 20573155 DOI: 10.1111/j.1365-2222.2010.03564.x] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND Nuclear factor (NF)-κB is a transcription factor that regulates cytokine and chemokine production in various inflammatory diseases, including bronchial asthma. IκB kinase (IKK) β is important for NF-κB activation in inflammatory conditions, and is possibly related to airway remodelling. Thus, inhibition of the IKKβ-NF-κB pathway may be an ideal strategy for the management of airway remodelling. OBJECTIVE We examined the effects of a newly synthesized IKKβ inhibitor, IMD-0354, in a chronic allergen exposure model of bronchial asthma in mice. METHODS A chronic mouse model was generated by challenge with house dust mite antigen (Dermatophagoides pteronyssinus). IMD-0354 was administrated intraperitoneally in therapeutic groups. Lung histopathology, hyperresponsiveness and the concentrations of mediators and molecules in supernatants of lung homogenates were determined. RESULTS NF-κB activation was inhibited by prolonged periods of IMD-0354 administration. IMD-0354 reduced the numbers of bronchial eosinophils. IMD-0354 also inhibited the pathological features of airway remodelling, including goblet cell hyperplasia, subepithelial fibrosis, collagen deposition and smooth muscle hypertrophy. Inhibition of these structural changes by IMD-0354 was the result of the suppressing the production and activation of remodelling-related mediators, such as TGF-β, via inhibition of IKKβ. IMD-0354 inhibited IL-13 and IL-1β production, and it restored the production of IFN-γ. It also ameliorated airway hyperresponsiveness. CONCLUSION IKKβ plays crucial roles in airway inflammation and remodelling in a chronic mouse model of asthma. A specific IKKβ inhibitor, IMD-0354, may be therapeutically beneficial for treating airway inflammation and remodelling in chronic asthma.
Collapse
Affiliation(s)
- H Ogawa
- Department of Respiratory Medicine & Rheumatology Department of Molecular and Environmental Pathology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Saegusa Y, Takeda H, Muto S, Nakagawa K, Ohnishi S, Sadakane C, Nahata M, Hattori T, Asaka M. Decreased plasma ghrelin contributes to anorexia following novelty stress. Am J Physiol Endocrinol Metab 2011; 301:E685-96. [PMID: 21712530 DOI: 10.1152/ajpendo.00121.2011] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
We hypothesized that anorexia induced by novelty stress caused by exposure to a novel environment may be due to activation of corticotropin-releasing factor (CRF) and subsequently mediated by decreasing peripheral ghrelin concentration via serotonin (5-HT) and melanocortin-4 receptors (MC4R). Each mouse was transferred from group-housed cages to individual cages to establish the novelty stress. We observed the effect of changes in feeding behavior in a novel environment using the method of transferring group-housed mice to individual cages. We investigated the effect of an intracerebroventricular injection of antagonists/agonists of CRF1/2 receptors (CRF1/2Rs), 5-HT(1B)/(2C) receptors (5-HT(1B)/(2C)R), and MC4R to clarify the role of each receptor on the decrease in food intake. Plasma ghrelin levels were also measured. The novelty stress caused a reduction in food intake that was abolished by administering a CRF1R antagonist. Three hours after the novelty stress, appetite reduction was associated with reduced levels of neuropeptide Y/agouti-related peptide mRNA, increased levels of proopiomelanocortin mRNA in the hypothalamus, and a decrease in plasma ghrelin level. Administering a CRF1R antagonist, a 5-HT(1B)/(2C)R antagonist, an MC4R antagonist, exogenous ghrelin, and an enhancer of ghrelin secretion, rikkunshito, resolved the reduction in food intake 3 h after the novelty stress by enhancing circulating ghrelin concentrations. We showed that anorexia during a novelty stress is a process in which CRF1R is activated at the early stage of appetite loss and is subsequently activated by a 5-HT(1B)/(2C)R and MC4R stimulus, leading to decreased peripheral ghrelin concentrations.
Collapse
Affiliation(s)
- Yayoi Saegusa
- Department of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Hisasue SI, Ide H, China T, Isotani S, Muto S, Yamaguchi R, Horie S. Initial experience of low energy shockwaves for the treatment of erectile dysfunction in Teikyo University Hospital, Japan. Journal of Men's Health 2011. [DOI: 10.1016/j.jomh.2011.08.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
39
|
Saegusa Y, Takeda H, Muto S, Oridate N, Nakagawa K, Sadakane C, Nahata M, Harada Y, Iizuka M, Hattori T, Asaka M. Decreased motility of the lower esophageal sphincter in a rat model of gastroesophageal reflux disease may be mediated by reductions of serotonin and acetylcholine signaling. Biol Pharm Bull 2011; 34:704-11. [PMID: 21532161 DOI: 10.1248/bpb.34.704] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
To elucidate the altered function of the lower esophageal sphincter (LES) in gastroesophageal reflux disease (GERD), we evaluated the motility proximal to LES using force transducers, contraction and relaxation responses to neurotransmitters in LES strips, and gene expression of neurotransmitter receptors in GERD rats. Force transducers were applied to the proximal LES, and contraction of the LES was monitored during free moving. In addition, LES was isolated from sham-operated and GERD rats to investigate the LES function in an organ bath, and to determine gene expression. The in vivo motility proximal to LES (% motility index) in conscious rats was decreased by atropine treatment and increased by cisapride (5-HT(4) receptor agonist) treatment. Acetylcholine- and serotonin (5-HT)-induced LES contraction and sodium nitroprusside-induced relaxation in LES strips of GERD rats markedly decreased compared to sham-operated rats. The mRNA expressions of 5-HT(4) and muscarinic acetylcholine 3 receptors were significantly reduced in esophageal LES strips of GERD rats compared with sham-operated rats. Intraperitoneal administration of cisapride improves the erosive damage in the esophagus in GERD rats. It is suggested that the reduction of 5-HT-induced contraction in LES strips in GERD rats may be partly due to the decrease in 5-HT(4)-receptor activation. The reduction of LES function may be due to the decrease in neurotransmitters signal transduction, leading to the deterioration of histopathological damage in GERD.
Collapse
Affiliation(s)
- Yayoi Saegusa
- Department of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Ide H, Yu J, Lu Y, Muto S, Horie S. 29 Prostate cancer in the aging male. Journal of Men's Health 2011. [DOI: 10.1016/s1875-6867(11)60062-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
41
|
Masuda T, Murata M, Honma S, Iwazu Y, Sasaki N, Ogura M, Onishi A, Ando Y, Muto S, Shimada K, Kario K, Kusano E, Asano Y. Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients. Nephrol Dial Transplant 2011; 26:2289-95. [DOI: 10.1093/ndt/gfq756] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Endo N, Sasaki R, Muto S. Pheromonal cross-attraction in true bugs (Heteroptera): attraction of Piezodorus hybneri (Pentatomidae) to its pheromone versus the pheromone of Riptortus pedestris (Alydidae). Environ Entomol 2010; 39:1973-1979. [PMID: 22182564 DOI: 10.1603/en10016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
We investigated the attractiveness of a synthetic form of the pheromone of the soybean stink bug, Piezodorus hybneri (Gmelin), under field conditions, and compared it with that of (E)-2-hexenyl (E)-2-hexenoate, a pheromone component of a competitor, Riptortus pedestris (Fabricius). Many adult stink bugs were attracted to traps baited with 100 mg of the synthetic pheromone (1: 1: one mixture of β-sesquiphellandrene, (R)-15-hexadecanolide, and methyl (Z)-8-hexadecenoate), but few were attracted to 1 or 10 mg. More than twice as many females as males were attracted to this male-produced pheromone. None of the individual pheromone components (30 mg) attracted conspecifics. In summer (June-July), when field P. hybneri were not in diapause, (E)-2-hexenyl (E)-2-hexenoate was more attractive to P. hybneri than the synthetic pheromone. The sex ratio of the adults attracted to the synthetic pheromone was highly female-biased, yet almost equal numbers of both sexes were attracted to (E)-2-hexenyl (E)-2-hexenoate. Most females attracted to both attractants were mated and had mature ovaries. However, adults attracted to (E)-2-hexenyl (E)-2-hexenoate were likely to have less food in their stomach than those attracted to the synthetic pheromone. In late autumn (October-November), when the bugs were in reproductive diapause, both attractants attracted many sexually immature female and male adults that had well-developed fat body. The synthetic pheromone also attracted a large number of conspecific nymphs. These results suggest that P. hybneri pheromone and R. pedestris pheromone component, respectively, have different functions for P. hybneri. The male-produced pheromone system of P. hybneri seems to be sex-related but to have other roles.
Collapse
Affiliation(s)
- N Endo
- National Agricultural Research Center for Kyushu Okinawa Region, 2421 Suya, Koshi, Kumamoto 861-1192, Japan.
| | | | | |
Collapse
|
43
|
Matsuda A, Tanaka A, Muto S, Ohmori K, Furusaka T, Jung K, Karasawa K, Okamoto N, Oida K, Itai A, Matsuda H. A novel NF-κB inhibitor improves glucocorticoid sensitivity of canine neoplastic lymphoid cells by up-regulating expression of glucocorticoid receptors. Res Vet Sci 2010; 89:378-82. [DOI: 10.1016/j.rvsc.2010.03.017] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2009] [Revised: 11/13/2009] [Accepted: 03/08/2010] [Indexed: 01/12/2023]
|
44
|
Onishi A, Muto S, Homma S, Inaba T, Shuto R, Kusano E, Asano Y. Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia. Clin Nephrol 2010; 74:403-408. [PMID: 20979951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
We describe here the interesting case of a 73-year-old hypertensive man with pseudoaldosteronism. He had been taking glycyrrhizin at a dose of 75 mg/day for 12 years because of mild liver damage, but had never experienced any previous symptoms associated with hypokalemia. He was referred to our hospital because of hypokalemic tetraparesis and rhabdomyolysis. At that time, we noted mineralocorticoid excess characterized by hypokalemia due to urinary K loss, exacerbation of hypertension due to increased tubular Na reabsorption, metabolic alkalosis, and suppression of both plasma renin activity and plasma aldosterone concentration. His urinary free cortisol excretion rate and the urinary ratio of free cortisol to free cortisone were markedly elevated. Thus we diagnosed pseudoaldosteronism that was related to the long-term use of glycyrrhizin. When he developed pseudoaldosteronism, he also contracted pneumonia, and exhibited elevated levels of serum cortisol and creatinine clearance (CCr) as well as hypouricemia, hypocalcemia, and hypophosphatemia. All normalized after the recovery from pneumonia and the administration of spironolactone. The extracellular volume expansion associated with increased tubular Na reabsorption by the aldosterone-sensitive distal nephron and the resulting increase in CCr caused an inhibition of proximal tubular reabsorption of uric acid, Ca, and inorganic phosphate, leading to their renal loss and therefore hypouricemia, hypocalcemia, and hypophosphatemia, respectively. In this patient, the increased circulating cortisol associated with the stress of inflammation caused by pneumonia triggered the development of pseudoaldosteronism.
Collapse
Affiliation(s)
- A Onishi
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
| | | | | | | | | | | | | |
Collapse
|
45
|
Takeda H, Muto S, Onishi S, Asaka M. [Role of Kampo medicine in the treatment of dyspepsia and anorexia]. Nihon Shokakibyo Gakkai Zasshi 2010; 107:1586-1591. [PMID: 20938108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Affiliation(s)
- Hiroshi Takeda
- Department of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University.
| | | | | | | |
Collapse
|
46
|
Fujimichi Y, Muto S, Tatsumi K, Kawano T, Yamane H. Quantitative determination of site occupancy of multi-rare-earth elements doped into Ca2SnO4 phosphor by electron channeling microanalysis. J SOLID STATE CHEM 2010. [DOI: 10.1016/j.jssc.2010.07.026] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
47
|
Tamura T, Mitsumori K, Muto S, Kasahara H, Kobayashi S, Okuhara Y, Hayashi M, Nagasawa T, Onozato T, Kuroda J. Fifty-two week chronic toxicity of enzymatically decomposed rutin in Wistar rats. Food Chem Toxicol 2010; 48:2312-8. [DOI: 10.1016/j.fct.2010.05.065] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2009] [Revised: 04/30/2010] [Accepted: 05/24/2010] [Indexed: 10/19/2022]
|
48
|
Kawahata K, Peterson BJ, Akiyama T, Ashikawa N, Emoto M, Funaba H, Hamada Y, Ida K, Inagaki S, Ido T, Isobe M, Goto M, Mase A, Masuzaki S, Michael C, Morisaki T, Morita S, Muto S, Nagayama Y, Nakamura Y, Nakanishi H, Sakamoto R, Narihara K, Nishiura M, Ohdachi S, Okajima S, Osakabe M, Sakakibara S, Sanin A, Sasao M, Sato K, Shimizu A, Shoji M, Sudo S, Tamura N, Tanaka K, Toi K, Tokuzawa T, Veshchev EV, Vyacheslavov LN, Yamada I, Yoshinuma M. Overview of LHD Plasma Diagnostics. Fusion Science and Technology 2010. [DOI: 10.13182/fst10-a10819] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- K. Kawahata
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - B. J. Peterson
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - T. Akiyama
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - N. Ashikawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - M. Emoto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - H. Funaba
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - Y. Hamada
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - K. Ida
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - S. Inagaki
- Kyushu University, Kasuga 816-8580, Japan
| | - T. Ido
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - M. Isobe
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - M. Goto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - A. Mase
- Kyushu University, Kasuga 816-8580, Japan
| | - S. Masuzaki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - C. Michael
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - T. Morisaki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - S. Morita
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - S. Muto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - Y. Nagayama
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - Y. Nakamura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - H. Nakanishi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - R. Sakamoto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - K. Narihara
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - M. Nishiura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - S. Ohdachi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - S. Okajima
- Chubu University, Kasugai 487-8501, Japan
| | - M. Osakabe
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - S. Sakakibara
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - A. Sanin
- Budkel Institute of Nuclear Physics, Novosibirsk 630090, Russia
| | - M. Sasao
- Tohoku University, Sendai 980-8579, Japan
| | - K. Sato
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - A. Shimizu
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - M. Shoji
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - S. Sudo
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - N. Tamura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - K. Tanaka
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - K. Toi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - T. Tokuzawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - E. V. Veshchev
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | | | - I. Yamada
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | - M. Yoshinuma
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
| | | |
Collapse
|
49
|
Ueno O, Samejima M, Muto S, Miyachi S. Photosynthetic characteristics of an amphibious plant, Eleocharis vivipara: Expression of C(4) and C(3) modes in contrasting environments. Proc Natl Acad Sci U S A 2010; 85:6733-7. [PMID: 16593980 PMCID: PMC282052 DOI: 10.1073/pnas.85.18.6733] [Citation(s) in RCA: 83] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Eleocharis vivipara Link, a freshwater amphibious leafless plant belonging to the Cyperaceae can grow in both terrestrial and submersed aquatic conditions. Two forms of E. vivipara obtained from these contrasting environments were examined for the characteristics associated with C(4) and C(3) photosynthesis. In the terrestrial form (delta (13)C values = -13.5 to -15.4 per thousand, where per thousand is parts per thousand), the culms, which are photosynthetic organs, possess a Kranz-type anatomy typical of C(4) plants, and well-developed bundle-sheath cells contain numerous large chloroplasts. In the submersed form (delta (13)C value = -25.9 per thousand), the culms possess anatomical features characteristic of submersed aquatic plants, and the reduced bundle-sheath cells contain only a few small chloroplasts. (14)C pulse-(12)C chase experiments showed that the terrestrial form and the submersed form fix carbon by way of the C(4) pathway, with aspartate (40%) and malate (35%) as the main primary products, and by way of the C(3) pathway, with 3-phosphoglyceric acid (53%) and sugar phosphates (14%) as the main primary products, respectively. The terrestrial form showed photosynthetic enzyme activities typical of the NAD-malic enzyme-C(4) subtype, whereas the submersed form showed decreased activities of key C(4) enzymes and an increased ribulose 1,5-bisphosphate carboxylase (EC 4.1.1.39) activity. These data suggest that this species can differentiate into the C(4) mode under terrestrial conditions and into the C(3) mode under submersed conditions.
Collapse
Affiliation(s)
- O Ueno
- Institute of Applied Microbiology, University of Tokyo, Bunkyo-ku, Tokyo 113, Japan
| | | | | | | |
Collapse
|
50
|
Ide H, Terado Y, Tokiwa S, Nishio K, Saito K, Isotani S, Kamiyama Y, Muto S, Imamura T, Horie S. Novel Germ Line Mutation p53-P177R in Adult Adrenocortical Carcinoma Producing Neuron-specific Enolase as a Possible Marker. Jpn J Clin Oncol 2010; 40:815-8. [DOI: 10.1093/jjco/hyq045] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|